The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
Casanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.005 · Cited by 1,621
Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., & Keshet, E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5028 · Cited by 1,241
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170
Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Baluk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 983
Cellular Regulation of RGS Proteins: Modulators and Integrators of G Protein Signaling
Hollinger, S., & Hepler, J. R. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.527 · Cited by 726
Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats.
Lin, T. N., He, Y. Y., Wu, G., Khan, M., & Hsu, C. Y. (1993) · Stroke · doi:10.1161/01.str.24.1.117 · Cited by 722
Pharmacokinetic Parameters in CNS Gd-DTPA Enhanced MR Imaging
Brix, G., Semmler, W., Port, R., Schad, L. R., Layer, G., & Lorenz, W. J. (1991) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199107000-00018 · Cited by 659
Jain, R. K., Tong, R. T., & Munn, L. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4102 · Cited by 612
Song, S., Ewald, A. J., Stallcup, W., Werb, Z., & Bergers, G. (2005) · Nature Cell Biology · doi:10.1038/ncb1288 · Cited by 548
Buckanovich, R. J., Facciabene, A., Kim, S., Benencia, F., Sasaroli, D., Balint, K., Katsaros, D., O'Brien-Jenkins, A., Gimotty, P. A., & Coukos, G. (2008) · Nature Medicine · doi:10.1038/nm1699 · Cited by 546
Pericytes: Cell Biology and Pathology
Allt, G., & Lawrenson, J. G. (2001) · Cells Tissues Organs · doi:10.1159/000047855 · Cited by 452
Genes that Distinguish Physiological and Pathological Angiogenesis
Seaman, S., Stevens, J., Yang, M. Y., Logsdon, D., Graff-Cherry, C., & St. Croix, B. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.017 · Cited by 419
Workshop R: Tumor Immunology, Abstract R1 bis R30
(2001) · Immunobiology · doi:10.1016/s0171-2985(04)70018-2 · Cited by 312
Hata, R., Mies, G., Wiessner, C., Fritze, K., Hesselbarth, D., Brinker, G., & Hossmann, K.-A. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199804000-00004 · Cited by 280
Bondjers, C., Kalén, M., Hellström, M., Scheidl, S. J., Abramsson, A., Renner, O., Lindahl, P., Cho, H., Kehrl, J., & Betsholtz, C. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63868-0 · Cited by 246
Berger, M., Bergers, G., Arnold, B., Hämmerling, G. J., & Ganss, R. (2005) · Blood · doi:10.1182/blood-2004-06-2315 · Cited by 222
Self-citationChen, C., Zheng, B., Han, J., & Lin, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8679 · Cited by 154
Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes.
Ganss, R., & Hanahan, D. (1998) · PubMed · Cited by 132
Self-citationGarbi, N., Arnold, B., Gordon, S., Hämmerling, G. J., & Ganß, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5861 · Cited by 128
Self-citationTransformation of the microvascular system during multistage tumorigenesis
Ryschich, E., Schmidt, J., Hämmerling, G. J., Klar, E., & Ganß, R. (2002) · International Journal of Cancer · doi:10.1002/ijc.10074 · Cited by 97
Self-citationNovel endothelial cell markers in hepatocellular carcinoma
Chen, X., Higgins, J., Cheung, S., Li, R., Mason, V., Montgomery, K. D., Fan, S.-T., van de Rijn, M., & So, S. K. (2004) · Modern Pathology · doi:10.1038/modpathol.3800167 · Cited by 87
Ryschich, E., Lizdenis, P., Ittrich, C., Benner, A., Stahl, S. H., Hamann, A., Schmidt, J., Knolle, P. A., Arnold, B., Hämmerling, G. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1636 · Cited by 86
Self-citationMini‐review: Overcoming tumor‐intrinsic resistance to immune effector function
Ganß, R., Arnold, B., & Hämmerling, G. J. (2004) · European Journal of Immunology · doi:10.1002/eji.200425474 · Cited by 75
Self-citationFuruya, M., Nishiyama, M., Kimura, S., Suyama, T., Naya, Y., Itô, H., Nikaido, T., & Ishikura, H. (2004) · The Journal of Pathology · doi:10.1002/path.1543 · Cited by 71
Boß, C. N., Grünebach, F., Brauer, K. M., Häntschel, M., Mirakaj, V., Weinschenk, T., Stevanović, S., Rammensee, H., & Brossart, P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2156 · Cited by 54
Cited by
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653
“Experimental pancreatic cancer grown in mice deficient for the pericyte marker RGS5 showed increased pericyte maturation and vascular normalization, which correlated with diminished vessel leakiness and hypoxia (Hamzah et al., 2008).”
BackgroundT cell exclusion, immune privilege, and the tumor microenvironment
Joyce, J. A., & Fearon, D. T. (2015) · Science · doi:10.1126/science.aaa6204 · Cited by 2,473
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
Therapeutic Targeting of the Tumor Microenvironment
Bejarano, L., Jordāo, M. J. C., & Joyce, J. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1808 · Cited by 1,653
Metadata
- Authors
- Hamzah, J., Jugold, M., Kiessling, F., Rigby, P., Manzur, M., Marti, H. H., Rabie, T., Kaden, S., Gröne, H.-J., Hämmerling, G. J., Arnold, B., & Ganss, R.
- Venue
- Nature
- Published
- 2008-04-16
- Volume
- 453
- Issue
- 7193
- Pages
- 410-414
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2070636596
- Cited by
- 564
- References
- 29
- FWCI
- 14.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.